Records containing: Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-02-10A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of PRX002 Administered by Intravenous Infusion in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2015-02-10Single-centre Open Label Exploratory Phase IIb Pilot Study of Exogenous Oral Melatonin for the Treatment of Nocturia in Adults With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2015-02-09The Effect of Exercise on Individuals With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2015-02-05ClinicalTrials.gov study NCT01382342
-
CLINICAL_TRIALS study record update · 2015-01-29A Randomized, Double-Blind, Placebo-Controlled, 2-Period Crossover Study to Evaluate Effectiveness of Single-Dose MK0657 in Combination With Levodopa on Motor Symptoms and Dyskinesias in Patients With Parkinson's Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-01-27A Randomized, Single-blind Trial on the Efficacy and Safety of L-dopa Monotherapy Versus Dopamine Agonists Monotherapy After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2015-01-26From Mouse Models to Patients: Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
-
CLINICAL_TRIALS study record update · 2015-01-16Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects
-
CLINICAL_TRIALS study record update · 2015-01-15Open-label, Single-dose, Multi-center Study, Investigating the Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment
-
CLINICAL_TRIALS study record update · 2015-01-13Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon Treated With Levodopa Plus a Dopa Decarboxylase Inhibitor (DDCI): a Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre Clinical Study.
-
CLINICAL_TRIALS study record update · 2015-01-12A Double-blind, Randomised, Placebo-controlled, Cross-over Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067 on the Levodopa Pharmacokinetics, Motor Response, and Erythrocyte Soluble Catechol-O-methyltransferase Activity in Parkinson's Disease Patients Concomitantly Treated With Levodopa/Dopa-decarboxylase Inhibitor
-
CLINICAL_TRIALS study record update · 2015-01-12A Randomized, Double-blind, Placebo Controlled, Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Idiopathic Parkinson's Disease (PD) of Moderate Severity, Using an Implanted Catheter and a SynchroMed® II Pump.
-
CLINICAL_TRIALS study record update · 2015-01-08A Single Dose Study to Assess the Pharmacokinetics of SCH 900800 Administered as Oral Tablets in L-DOPA-treated Subjects With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2015-01-08Multicentre, Double-blind, Randomised, Placebo-controlled Study in Four Parallel Groups of PD Patients Treated With Standard-release Levodopa/Carbidopa 100/25 mg (Sinemet®) or Levodopa/Benserazide 100/25 mg (Madopar®/Restex®) and With Motor Fluctuations ("Wearing-off" Phenomenon)
-
CLINICAL_TRIALS study record update · 2015-01-08Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon Treated With Levodopa Plus a Dopa Decarboxylase Inhibitor (DDCI): a Double-blind, Randomised, Placebo- and Active-controlled, Parallel-group, Multicentre Clinical Study
-
CLINICAL_TRIALS study record update · 2014-12-23Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China
-
CLINICAL_TRIALS study record update · 2014-12-18Assessment of Cobalamin Status and Responses to Supplementation in Patients With Parkinson's Disease : a Pilot Study
-
CLINICAL_TRIALS study record update · 2014-12-02Effect of Opicapone at Steady State on Warfarin Pharmacokinetics in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2014-11-13The ParkCycle Study: Effects of Aerobic Exercise on Cognitive and Adaptive Plasticity in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2014-11-13Lipopolysaccharide Binding Protein as a Potential Biomarker of Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2014-11-06Pilot Study of Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2014-11-05Treating Depression in Parkinson's Disease: A New Method
-
CLINICAL_TRIALS study record update · 2014-11-03The Effects of Treadmill Versus Agility Training in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2014-11-03Development of an Instrumented System to Measure Mobility in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2014-10-31Adding Orally Disintegrating Selegiline (Zelapar) to Patients Taking Dopamine Agonists and Experiencing Complications